GlassScriptPhysician profile
Alexandra Loyd
NPI 1962193201
$877.54
in general payments reported to CMS, 2019-2025
16 companies · $778 in 2025
The $778 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $99.89 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $250.51 | 2024-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $146.62 | 2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $81.31 | 2025 | Mounjaro, Zepbound |
| Axsome Therapeutics, INC. | $73.40 | 2025 | Auvelity |
| Exact Sciences Corporation | $65.01 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $47.50 | 2025 | |
| Amgen INC. | $32.67 | 2025 | Krystexxa |
| Astellas Pharma US INC | $26.23 | 2025 | Veozah |
| Corcept Therapeutics | $23.43 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.26 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.89 | 2025 | Xifaxan |
| Dynavax Technologies Corporation | $19.62 | 2025 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $17.31 | 2025 | |
| Tonix Medicines, INC. | $16.83 | 2025 | Tonmya |
| Lundbeck LLC | $16.59 | 2025 | Vyepti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Loyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.